Sepsis Survivors Experience Lingering Effects
New research to be presented at the 2017 Pediatric Academic Societies Meeting shows that despite the fact that survival rates among children who develop sepsis have risen dramatically in recent years, recovery still remains a long haul for these patients. Many of them continue to feel the physical, social and emotional effects long after they are discharged from the hospital.
See Also: Vitamin C in Severe Sepsis Treatment
Lead author Elizabeth Killien, a pediatric critical care medicine fellow at the University of Washington School of
Medicine explains that the number of children experiencing sepsis continues to increase and while survival rates are improving, very little is known about what happens to these children once they leave the hospital.
During this study, researchers reviewed the electronic health records of 778 children who met the sepsis criteria within four hours of arrival. Patients' health-related quality of life and overall level of functional well-being was compared at baseline, 2 weeks and 5 months after hospital discharge.
"What we found was that more than 23 percent, or nearly a quarter, of the patients hospitalised with sepsis
have a significant decline in quality of life after hospitalisation that can last several months after discharge,"
A strong predictor of failure to recover to baseline health-related quality of life was the severity of the patient's sepsis according to Dr. Killien. 50% of patients who developed septic shock with blood pressure plunges and organ damage were still below the baseline five months after discharge. 56% of patients who had sepsis that involved infections in the blood also failed to recover fully as did the 53% of patients who suffered from infections of the central nervous system.
Dr. Killien highlights the need to recognise that children who suffer from sepsis can have a significant impact on their long term well-being. By understanding which factors predict declines in quality of life, it may be possible to improve outcomes among sepsis survivors.
Source: American Academy of Pediatrics
Image Credit: Ron Mader
Published on : Fri, 5 May 2017
Print as PDF
The Accelerate PhenoTest™ BC kit is the first application of the Accelerate Pheno™ system. It provides with less 5 minutes operator hands-on time within 1.5 hour the identification of the most prevalent micro-organisms seen in blood stream infections....
Features The SynoVent E3 does not only include advanced ventilator functionality but also a modern, easy to use interface. The display can be configured to suit each clinician’s taste and needs, and gives quick and easy control over ventilator parameters...
The fully-automated Accelerate Pheno™ system is designed to eliminate the lengthy culture and sample preparation steps required for most sample types prior to antimicrobial susceptibility testing. In addition, it hosts proprietary molecular identification...
The iLA Membrane Ventilator is an extrapulmonary ventilation system which is used primarily to remove carbon dioxide. The heart pumps blood through it as it does through a natural organ. The gas exchange takes place via a plasma-tight, heparin-coated...
The HAMILTON-T1 combines for the first time the functionality of a fully featured intensive care unit ventilator with the compactness and ruggedness required for transport. This is why the HAMILTON-T1 enables you to provide optimal ventilation therapy...